Canalizo-Miranda E, Favela-Pérez EA, Salas-Anaya LA, Gómez-Díaz R, Jara-Espino R, Torres-Arreola LP, Viniegra-Osorio A

Language: Spanish
References: 16
Page: 700-709
PDF size: 204.05 Kb.

ABSTRACT

Non-communicable diseases are a public health problem in México. Coronary heart disease and diabetes mellitus are the fi rst and second cause of death in the country, followed by thrombotic cerebrovascular events. Cardiovascular diseases are the leading cause of death; one primary risk factor is hypercholesterolemia. The detection and treatment of lipid abnormalities is the key to the prevention and management of chronic non-communicable diseases. Two nationally representative surveys have shown that lipid abnormalities are the most common risk factors in Mexican adults. The purpose of this guide is to provide a basis for identifying dyslipidemia in a timely manner, and to systematize the criteria for diagnosis and treatment in the fi rst and second level of care.

REFERENCES

1. Olaiz-Fernández G, Rivera-Dommarco J, Shamah- Levy T, Rojas R, Villalpando-Hernández S, Hernández- Ávila M, et al. Encuesta Nacional de Salud y Nutrición, 2006. Cuernavaca, México: Instituto Nacional de Salud Pública; 2006.

2. The National Collaboration Centre for Primary Care. Lipid Modifi cation. Cardiovascular risk assessment and the modifi cation of blood lipids for the primary and secondary prevention of cardiovascular disease. NICE clinical guideline 67. London: Royal College of General Practitioners; 2008. Última modifi cación: marzo de 2010.

3. Aguilar-Salinas CA, Gómez-Díaz RA, Gómez-Pérez FJ. Dislipidemias de lo clínico a lo molecular. México: Intersistemas; 2008.

4. Aguilar-Salinas CA, Gómez-Pérez FJ, Lerman- Garber I, Vázquez-Chávez C, Pérez-Méndez O, Posadas-Romero C. Diagnóstico y tratamiento de las dislipidemias. Posición de la Sociedad Mexicana de Nutrición y Endocrinología. Rev Endocrinol Nutr. 2004;12(1):7-41.

5. Secretaría de Salud. Norma ofi cial mexicana NOM- 037-SSA2-2012, para la prevención, tratamiento y control de las dislipidemias. Diario Ofi cial de la Federación del 13 de julio de 2012.

6. Kodama S, Tanaka S, Saito K, Shu M, Sone Y, Onitake F, et al. Effect of aerobic exercise training on serum levels of high-density lipoprotein cholesterol: a meta-analysis. Arch Intern Med. 2007;167 (10):999-1008.

7. European Association for Cardiovascular Prevention & Rehabilitation, Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, et al. ESC/EAS guidelines for the management of dislipidemias: The Task Force for the management of dyslipidemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Hearth J. 2011;32:1769-818.

8. Kelley GA, Kelley KS, Franklin B. Aerobic exercise and lipids and lipoproteins in patients with cardiovascular disease: a meta-analysis of randomized controlled trials. J Cardiopulm Rehabil. 2006;26(3):131-9.

9. Grundy SM, Cleeman JI, Bairey N, Brewer B, Clark L, Hunninghake D, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Arterioscler Thromb Vasc Biol. 2004;24:e149-61.

10. Cooper A, Nherera L, Calvert N, O’Flynn N, Turnbull N, Robson Jl, et al. Lipid modifi cation: cardiovascular risk assessment and the modifi cation of blood lipids for the primary and secondary prevention of cardiovascular disease. London: National Collaborating Centre for Primary Care and Royal College of General Practitioners; 2008.

11. Institute for Clinical Systems Improvement. [Sitio web]. Guidelines and more. Lipid management in adults. Eleventh edition. Institute for Clinical Systems Improvement; 2009. Disponible en https:// www.icsi.org/guidelines__more/catalog_guidelines_ and_more/catalog_guidelines/catalog_ cardiovascular_ guidelines/lipid/

12. Ministry of Health. Clinical Practice Guidelines. Lipids. Singapore: Ministry of Health; 2006.

13. Genest J, McPherson R, Frohlich J, Anderson T, Campbell N, Carpentier A, et al. 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult – 2009 recommendations. Can J Cardiol. 2009;25(10):567-79.

14. American Dietetic Association. Disorders of lipid metabolism. Evidence-based nutrition practice guideline. Chicago (IL): American Dietetic Association; 2011.

15. Caja Costarricense de Seguro Social. Guías para la detección, el diagnóstico y el tratamiento de las dislipidemias para el primer nivel de atención. San José de Costa Rica: Caja Costarricense de Seguro Social; 2004.

16. Rajpathak SN, Kumbhani DJ, Crandall J, Barzilai M, Alderman M, Ridker PM. Statin therapy and risk of developing type 2 diabetes: a meta-analysis. Diabetes Care. 2009;32(10):1924-9.